Sqz Biotechnologies's

• SQZB's Stock Performance relative to its Competitors

Dyadic International Inc Share Performance -47.68% 30 Days

Dyadic International Inc Profile Dyadic International Inc's business model revolves around developing and licensing proprietary microbial strains and technologies for use in the biopharmaceutical, biofuels, and industrial enzyme industries. More about Dyadic International Inc 's Market Share

Lexeo Therapeutics Inc Share Performance -22.20% One Year

Lexeo Therapeutics Inc Profile Lexeo Therapeutics Inc is a biotechnology company focused on developing advanced gene therapies for the treatment of genetic disorders. Their business model revolves around leveraging cutting-edge technology and scientific expertise to develop innovative gene therapies that address significant unmet medical needs. They aim to bring these therapies to market through strategic partnerships and collaborations with pharmaceutical companies and academic institutions. More about Lexeo Therapeutics Inc 's Market Share

Meiragtx Holdings Plc Share Performance -6.68% 30 Days

Meiragtx Holdings Plc Profile MeiraGTx Holdings Plc is a biotechnology company focused on developing gene therapies for inherited and acquired diseases. They leverage their proprietary technology to develop and commercialize innovative treatments that address unmet medical needs. More about Meiragtx Holdings Plc's Market Share

Molecular Partners Ag Share Performance +10.44% One Year

Molecular Partners Ag Profile Molecular Partners Ag is a biotechnology company that operates on an innovative business model focused on the development of therapeutic drugs. The company utilizes its proprietary DARPin technology platform to create a pipeline of potential treatments for various diseases. Molecular Partners Ag primarily collaborates with strategic partners, including pharmaceutical companies, to advance its drug candidates through preclinical and clinical development stages. More about Molecular Partners Ag's Market Share

Moderna Inc Share Performance +7.50% Over The Past 5 Days

Moderna Inc Profile Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases. More about Moderna Inc 's Market Share

Sources: Sqz Biotechnologies Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:37 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sqz Biotechnologies Company versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.